Tavin LN Tablet is a combination medication designed to treat HIV (Human Immunodeficiency Virus) infection. Each tablet contains three active ingredients: Lamivudine (300 mg), Tenofovir disoproxil fumarate (300 mg), and Nevirapine (245 mg). This powerful trio works synergistically to inhibit the replication of the virus, thereby helping to manage the infection effectively. Lamivudine and Tenofovir are both nucleoside reverse transcriptase inhibitors (NRTIs), while Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Together, they provide a comprehensive approach to HIV treatment, improving the quality of life for patients and reducing the risk of transmission. Tavin LN Tablet is typically prescribed as part of a broader antiretroviral therapy regimen and is essential for individuals living with HIV to maintain viral suppression and prevent the progression to AIDS.